Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience

Autor: Paul A. De Sousa, Rachel Steeg, Elisabeth Wachter, Kevin Bruce, Jason King, Marieke Hoeve, Shalinee Khadun, George McConnachie, Julie Holder, Andreas Kurtz, Stefanie Seltmann, Johannes Dewender, Sascha Reimann, Glyn Stacey, Orla O'Shea, Charlotte Chapman, Lyn Healy, Heiko Zimmermann, Bryan Bolton, Trisha Rawat, Isobel Atkin, Anna Veiga, Bernd Kuebler, Blanca Miranda Serano, Tomo Saric, Jürgen Hescheler, Oliver Brüstle, Michael Peitz, Cornelia Thiele, Niels Geijsen, Bjørn Holst, Christian Clausen, Majlinda Lako, Lyle Armstrong, Shailesh K. Gupta, Alexander J. Kvist, Ryan Hicks, Anna Jonebring, Gabriella Brolén, Andreas Ebneth, Alfredo Cabrera-Socorro, Patrik Foerch, Martine Geraerts, Tina C. Stummann, Shawn Harmon, Carol George, Ian Streeter, Laura Clarke, Helen Parkinson, Peter W. Harrison, Adam Faulconbridge, Luca Cherubin, Tony Burdett, Cesar Trigueros, Minal J Patel, Christa Lucas, Barry Hardy, Rok Predan, Joh Dokler, Maja Brajnik, Oliver Keminer, Ole Pless, Philip Gribbon, Carsten Claussen, Annette Ringwald, Beate Kreisel, Aidan Courtney, Timothy E. Allsopp

Publikováno v: Stem Cell Research, Vol 20, Iss C, Pp 105-114 (2017)

A fast track “Hot Start” process was implemented to launch the European Bank for Induced Pluripotent Stem Cells (EBiSC) to provide early release of a range of established control and disease linked human induced pluripotent stem cell (hiPSC) line

Externí odkaz: https://doaj.org/article/d5c03414c1b04475bf195ed59dedab4f

Datasets of genes coexpressed with FBN1 in mouse adipose tissue and during human adipogenesis

Autor: Margaret R. Davis, Erik Arner, Cairnan R.E. Duffy, Paul A. De Sousa, Ingrid Dahlman, Peter Arner, Kim M. Summers

Publikováno v: Data in Brief, Vol 8, Iss , Pp 851-857 (2016)

This article contains data related to the research article entitled “Expression of FBN1 during adipogenesis: relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions” [1]. The article concerns the expression of FBN1, the

Externí odkaz: https://doaj.org/article/b364309db25b4f57ab9fd1e034b70dce

F12 Research participation: the view of persons at risk and persons with premanifest huntington’s disease

Autor: Zaynab Umakhanova, Paul A. De Sousa, Michaela Winkelmann, Rob Haselberg, Astri Arnesen, Marina Tretyakova, Danuta Lis, Beatrice De Schepper, Vladimír Václavík, Hans Gommans, Filipa Júlio, Emilie Hermant, Marios Papantoniou, Svein Olaf Olsen, Josè Perez Casanova, Cristina Ferreira, Ferdinando Squitieri, Ruth Blanco, Barbara D’Alessio, Sabrina Maffi, Dina De Sousa

Publikováno v: F: Clinical studies: case reports, observational studies and trials.

Background The development of effective therapies for Huntington’s disease (HD) requires an active, informed, and lasting commitment from HD families to research. Specifically, those traditionally less involved in studies should be heard and engage

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::36dc9885d09b8025453e84e38af537f0
https://doi.org/10.1136/jnnp-2021-ehdn.55

Human Embryonic Stem Cell Banking for Clinical Applications—20 Years from Their Isolation

Autor: Paul A. De Sousa

Publikováno v: Essentials of Tissue and Cells Banking ISBN: 9783030716202

Twenty years on from the first reported isolation of pluripotent human embryonic stem cells (hESC) from in vitro fertilised preimplantation embryos, clinical evaluation of derivative cell products is ongoing. Contrary to expectations that pluripotenc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::43eba47f3ad66e20f2979e01be60cd93
https://doi.org/10.1007/978-3-030-71621-9_15

Hot Start to European Pluripotent Stem Cell Banking

Autor: Rachel Steeg, Timothy E Allsopp, Paul A. De Sousa, Beate Kreisel

Publikováno v: De Sousa, P A, Steeg, R, Kreisel, B & Allsopp, T E 2017, ' Hot Start to European Pluripotent Stem Cell Banking ', Trends in biotechnology . https://doi.org/10.1016/j.tibtech.2017.04.006

Achieving consistency in standards of access to and quality of human induced pluripotent stem cells has lagged behind their use. In Europe, a network of academic and industrial partners has been established to overcome this challenge. The experience

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::483b07abb00f1e0b7541c600d3934437
https://doi.org/10.1016/j.tibtech.2017.04.006